How John Hancock backed the marketâs biggest winner
May 25, 2021 â 12.00am
Save
Share
It was a chat on a ski lift above Canadaâs playground for the rich that led John Hancock to make an investment that turned out to be Australiaâs best performing stock on the market over the past year.
And itâs this educated bet that has helped the Rinehart scion build on a wealth pile to edge ahead of his three younger siblings on this yearâs Financial Review Rich List, published on Friday.
âI was looking for an interesting project to get behind,â says John Hancock about his investment in Vulcan Energy, which is up 2675 per cent over the past year.Â
What itâs like to be the son of Australiaâs richest woman
After a decade of legal fights with his mother, John Hancock is making his own way in the world. And so far the returns are good. The Rich List issue is out on Friday, May 28.
John Hancock: âFor the first time in my life I had the ability to look after my family and also make decisions on investments.âÂ
May 25, 2021 â 12.04am
Save
Share
It was December 2020, John Hancock and his family were checking into a hotel just outside of Dubai, and they were drawing attention. Not because anyone recognised him as the eldest child and only son of Australiaâs richest person, Gina Rinehart. The problem was their luggage: along with suitcases, the Hancocks were hauling several pairs of snow skis.
Share this article
Share this article
FORT LEE, N.J., May 14, 2021 /PRNewswire/ Creatd, Inc. (Nasdaq CM: CRTD) ( Creatd or the Company ), is pleased to announce that it has closed a private placement of convertible notes and warrants, led by Lind Global Macro Fund, L.P., an institutional investment fund managed by The Lind Partners, LLC, (together, Lind ), for aggregate gross proceeds of $4.0 million. The financing also included two additional investors, both of whom exercised their right to participate, pursuant to the Company s December 2020 Preferred Series E offering. The notes are convertible into shares of Creatd s common stock at a price of $5.00 per share. The notes carry an original issue discount, making the aggregate principal amount $4.67 million. Additionally, the Company issued the investors an aggregate of 1,090,908 warrants, exercisable at a price of $4.50 per share. The Benchmark Company acted as exclusive Placement Agent for the financing.
Form 424B3 Predictive Oncology Inc streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Nasdaq & NYSE Penny Stocks To Watch This Week
We always talk about following trends when it comes to penny stocks. It might be a niche like electric vehicles or an entire sector like biotech. On this note, the latter has been one of the hottest corners of the stock market today. In fact, biotech and small-cap stocks were among the top performers of the week so far. Letâs take a few of the benchmark ETFs to show what Iâm talking about.
The NASDAQ Biotech ETF (IBB) and Russell 2000 Small-Cap ETF (IWM) reached fresh all-time highs. Meanwhile, the broader S&P 500 (SPY) came up short. Whatâs more, is that the Biotech ETF closed 9 cents shy of its high. The strength in small-cap biotech stocks may be something to take notice of right now. Thatâs also true in light of continued momentum stemming from vaccine stocks. With the new, more contagious variant identified in the U.S. this week, there could be a brighter spotlight on sector stocks.